BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 30431698)

  • 1. Correlation between SALL4 stemness marker and bone morphogenetic protein signaling genes in esophageal squamous cell carcinoma.
    Assarnia S; Ardalan Khales S; Forghanifard MM
    J Biochem Mol Toxicol; 2019 Mar; 33(3):e22262. PubMed ID: 30431698
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Crosstalk between MEIS1 and markers of different cell signaling pathways in esophageal squamous cell carcinoma.
    Mahmoudian RA; Forghanifard MM
    Mol Biol Rep; 2020 May; 47(5):3439-3448. PubMed ID: 32372171
    [TBL] [Abstract][Full Text] [Related]  

  • 3. SOX2/SALL4 stemness axis modulates Notch signaling genes to maintain self-renewal capacity of esophageal squamous cell carcinoma.
    Forghanifard MM; Kasebi P; Abbaszadegan MR
    Mol Cell Biochem; 2021 Feb; 476(2):921-929. PubMed ID: 33098486
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stemness state regulators SALL4 and SOX2 are involved in progression and invasiveness of esophageal squamous cell carcinoma.
    Forghanifard MM; Ardalan Khales S; Javdani-Mallak A; Rad A; Farshchian M; Abbaszadegan MR
    Med Oncol; 2014 Apr; 31(4):922. PubMed ID: 24659265
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MEIS1 promotes expression of stem cell markers in esophageal squamous cell carcinoma.
    Zargari S; Negahban Khameneh S; Rad A; Forghanifard MM
    BMC Cancer; 2020 Aug; 20(1):789. PubMed ID: 32819319
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of SALL4 reduces tumorigenicity involving epithelial-mesenchymal transition via Wnt/β-catenin pathway in esophageal squamous cell carcinoma.
    He J; Zhou M; Chen X; Yue D; Yang L; Qin G; Zhang Z; Gao Q; Wang D; Zhang C; Huang L; Wang L; Zhang B; Yu J; Zhang Y
    J Exp Clin Cancer Res; 2016 Jun; 35(1):98. PubMed ID: 27329034
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of DIDO1 in Progression of Esophageal Squamous Cell Carcinoma.
    Forghanifard MM; Naeimi Khorasanizadeh P; Abbaszadegan MR; Javdani Mallak A; Moghbeli M
    J Gastrointest Cancer; 2020 Mar; 51(1):83-87. PubMed ID: 30761474
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Contribution of KCTD12 to esophageal squamous cell carcinoma.
    Abbaszadegan MR; Taghehchian N; Li L; Aarabi A; Moghbeli M
    BMC Cancer; 2018 Aug; 18(1):853. PubMed ID: 30157793
    [TBL] [Abstract][Full Text] [Related]  

  • 9. SOX1 is correlated to stemness state regulator SALL4 through progression and invasiveness of esophageal squamous cell carcinoma.
    Rad A; Esmaeili Dizghandi S; Abbaszadegan MR; Taghechian N; Najafi M; Forghanifard MM
    Gene; 2016 Dec; 594(2):171-175. PubMed ID: 27576349
    [TBL] [Abstract][Full Text] [Related]  

  • 10. THG-1 suppresses SALL4 degradation to induce stemness genes and tumorsphere formation through antagonizing NRBP1 in squamous cell carcinoma cells.
    Hwang J; Haque MA; Suzuki H; Dijke PT; Kato M
    Biochem Biophys Res Commun; 2020 Mar; 523(2):307-314. PubMed ID: 31864704
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Contribution of MAML1 in esophageal squamous cell carcinoma tumorigenesis.
    Hashemi Bidokhti M; Abbaszadegan MR; Sharifi N; Abbasi Sani S; Forghanifard MM
    Ann Diagn Pathol; 2017 Apr; 27():79-82. PubMed ID: 28325367
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Homeobox D10, a tumor suppressor, inhibits the proliferation and migration of esophageal squamous cell carcinoma.
    Zhang J; Liu S; Zhang D; Ma Z; Sun L
    J Cell Biochem; 2019 Aug; 120(8):13717-13725. PubMed ID: 30938888
    [TBL] [Abstract][Full Text] [Related]  

  • 13. miR-32 promotes esophageal squamous cell carcinoma metastasis by targeting CXXC5.
    Liu YT; Zong D; Jiang XS; Yin L; Wang LJ; Wang TT; Zhu J; He X
    J Cell Biochem; 2019 Apr; 120(4):6250-6263. PubMed ID: 30362164
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MAML1 promotes ESCC aggressiveness through upregulation of EMT marker TWIST1.
    Forghanifard MM; Azaraz S; Ardalan Khales S; Morshedi Rad D; Abbaszadegan MR
    Mol Biol Rep; 2020 Apr; 47(4):2659-2668. PubMed ID: 32180088
    [TBL] [Abstract][Full Text] [Related]  

  • 15. SET domain-containing 5 is a potential prognostic biomarker that promotes esophageal squamous cell carcinoma stemness.
    Piao L; Li H; Feng Y; Yang Z; Kim S; Xuan Y
    Exp Cell Res; 2020 Apr; 389(1):111861. PubMed ID: 31981592
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Linkage between EMT and stemness state through molecular association between TWIST1 and NY-ESO1 in esophageal squamous cell carcinoma.
    Ardalan Khales S; Abbaszadegan MR; Majd A; Forghanifard MM
    Biochimie; 2019 Aug; 163():84-93. PubMed ID: 31158427
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predicting the molecular role of MEIS1 in esophageal squamous cell carcinoma.
    Rad A; Farshchian M; Forghanifard MM; Matin MM; Bahrami AR; Geerts D; A'rabi A; Memar B; Abbaszadegan MR
    Tumour Biol; 2016 Feb; 37(2):1715-25. PubMed ID: 26314854
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Contribution of EVX1 in Aggressiveness of Esophageal Squamous Cell Carcinoma.
    Mallak AJ; Abbaszadegan MR; Khorasanizadeh PN; Forghanifard MM
    Pathol Oncol Res; 2016 Apr; 22(2):341-7. PubMed ID: 26552663
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of MAML1 and MEIS1 in Esophageal Squamous Cell Carcinoma Depth of Invasion.
    Abbaszadegan MR; Moghbeli M
    Pathol Oncol Res; 2018 Apr; 24(2):245-250. PubMed ID: 28462489
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression analysis elucidates the roles of MAML1 and Twist1 in esophageal squamous cell carcinoma aggressiveness and metastasis.
    Forghanifard MM; Moaven O; Farshchian M; Montazer M; Raeisossadati R; Abdollahi A; Moghbeli M; Nejadsattari T; Parivar K; Abbaszadegan MR
    Ann Surg Oncol; 2012 Mar; 19(3):743-9. PubMed ID: 22006371
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.